Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) EBIT Margin (2020 - 2026)

SkinHealth Systems has reported EBIT Margin over the past 6 years, most recently at 0.2% for Q4 2025.

  • Quarterly EBIT Margin rose 877.0% to 0.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.92% through Dec 2025, up 1336.0% year-over-year, with the annual reading at 6.92% for FY2025, 1336.0% up from the prior year.
  • EBIT Margin was 0.2% for Q4 2025 at SkinHealth Systems, up from 8.83% in the prior quarter.
  • Over five years, EBIT Margin peaked at 5.01% in Q1 2021 and troughed at 84.28% in Q3 2023.
  • The 5-year median for EBIT Margin is 12.34% (2021), against an average of 16.6%.
  • Year-over-year, EBIT Margin plummeted -7938bps in 2023 and then skyrocketed 5698bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 13.48% in 2021, then skyrocketed by 81bps to 2.49% in 2022, then plummeted by -660bps to 18.96% in 2023, then skyrocketed by 55bps to 8.57% in 2024, then soared by 102bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for SKIN's EBIT Margin are 0.2% (Q4 2025), 8.83% (Q3 2025), and 3.45% (Q2 2025).